CareDx (NASDAQ: CDNA) grants 9,795 RSUs to board member Riggsbee

Rhea-AI Filing Summary

CareDx, Inc. reported that director Richard Bryan Riggsbee acquired 9,795 shares of common stock through a grant of restricted stock units. These RSUs were awarded at no cash cost per share and are a form of equity compensation, not an open-market purchase.

According to the filing, all of the RSUs vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately before the first Annual Meeting that occurs after the grant date, subject to his continuous service. Following this award, Riggsbee directly holds 39,312 shares of CareDx common stock.

Insider Trade Summary 10b5-1

1 transaction reported

Mixed 1 txn

Insider Riggsbee Richard Bryan

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,795	$0.00	--

Holdings After Transaction: Common Stock — 39,312 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 9,795 shares Grant price: $0.00 per share Shares owned after grant: 39,312 shares

3 metrics

RSUs granted 9,795 shares Restricted stock unit award to director on grant date

Grant price $0.00 per share Reported transaction price for RSU award

Shares owned after grant 39,312 shares Director’s direct CareDx common stock holdings post-transaction

Key Terms

restricted stock units ("RSUs"), Annual Meeting, continuous service

3 terms

restricted stock units ("RSUs") financial

"The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100%"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Annual Meeting financial

"on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

continuous service financial

"after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Riggsbee Richard Bryan

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		A		9,795(1)	A	$0	39,312	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did CareDx (CDNA) director Richard Bryan Riggsbee report in this Form 4?

Director Richard Bryan Riggsbee reported receiving 9,795 restricted stock units in CareDx common stock as an equity grant. The award was made at no cash cost per share and increased his direct holdings to 39,312 shares after the transaction.

How many CareDx (CDNA) shares did Richard Bryan Riggsbee acquire in the latest grant?

He acquired 9,795 shares of CareDx common stock through a restricted stock unit grant. These RSUs represent a compensation award, not an open-market purchase, and were added to his existing position, bringing his direct holdings to 39,312 shares.

What are the vesting terms of Richard Bryan Riggsbee’s new CareDx (CDNA) RSUs?

The 9,795 restricted stock units vest 100% on the earlier of the one-year anniversary of the grant or the day immediately before the first Annual Meeting after the grant. Vesting requires Riggsbee’s continuous service through the applicable vesting date.

Did Richard Bryan Riggsbee buy or sell CareDx (CDNA) shares on the open market?

He did not buy or sell shares on the open market. The Form 4 shows a grant of 9,795 restricted stock units as equity compensation at a reported price of $0.00 per share, which increased his direct ownership stake in CareDx.

What is Richard Bryan Riggsbee’s total direct ownership in CareDx (CDNA) after this RSU grant?

After the restricted stock unit grant, Riggsbee directly owns 39,312 shares of CareDx common stock. This figure includes the newly awarded 9,795 RSU-based shares that were added to his previously held position, as reported in the Form 4 filing.